Ten-year cardiovascular risk changes and major adverse events in gout patients
Authors:
- 14 September 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Abstract
Objective: The long-term interaction between cardiovascular (CV) risk profiles and gout may influence the risk of cardiovascular events. However, the impact of gout and long-term changes in CV risk profile on CV events is unclear. Methods: This was a nationwide cohort study based on the Korean National Health Insurance claims database and the National Health Screening Program. Patients aged 20–90 years newly diagnosed with gout after January 2012 and age- and sex-matched controls without gout were included. After adjusting for CV risk profiles measured 10 years before gout diagnosis and their long-term changes, the relative risks of incident CV events (myocardial infarction, cerebral infarction and cerebral haemorrhage) and all-cause death in the gout patients were assessed. Results: In total, 113 853 patients with gout and 1 138 530 matched controls were studied. Multivariable analysis showed that gout was associated with increased risks for myocardial infarction (hazard ratio [HR]: 1.39, P < 0.001), cerebral infarction (HR: 1.36, P < 0.001), cerebral haemorrhage (HR: 1.50, P < 0.001), and all-cause death (HR: 1.07, P = 0.004). In addition, significant interactions were observed for myocardial infarction (Grade 1 aggravation over 10 years of diastolic blood pressure [DBP], P = 0.042), cerebral infarction (Grade 2 aggravation over 10 years of DBP, P = 0.037) and cerebral haemorrhage (Grade 2 aggravation over 10 years of total cholesterol, P = 0.057). Conclusions: Gout patients had a high risk of incident CV events even after adjusting for CV risk profiles and their long-term changes. These long-term changes additively increase the risk of CV events in gout patients.Keywords
Funding Information
- Jeju National University Hospital
This publication has 42 references indexed in Scilit:
- Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With GoutJAMA, 2022
- Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With GoutJAMA Cardiology, 2019
- Epidemiology of gout in women: Fifty‐two–year followup of a prospective cohortArthritis & Rheumatism, 2010
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Gout and the risk of acute myocardial infarctionArthritis & Rheumatism, 2006
- Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in MenArchives of internal medicine (1960), 2005
- Validation of the Framingham Coronary Heart Disease Prediction ScoresJAMA, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Gout and Risk for Subsequent Coronary Heart DiseaseArchives of internal medicine (1960), 1997
- Endothelial activation in monosodium urate monohydrate crystal‐induced inflammation. In vitro and in vivo studies on the roles of tumor necrosis factor α and interleukin‐1Arthritis & Rheumatism, 1997